Skip to content

PDS Biotechnology Corp

Public company
Headquarters
PRINCETON, New Jersey
Ticker
PDSB
CIK
0001472091

WARN notices since 2024

0
None on record

Workers affected since 2024

0
Across 0 notices

Executive changes, last 12 months

13
7 appointments, 6 departures

Last event

Oct 20, 2026
Executive departuremember of the Board departs: Kamil Ali-Jackson, Esq.

Workers affected over time

Cumulative workers in WARN notices since 2024

Not enough notices to chart yet.

Leadership

Role and personSinceChange
member of the BoardKamil Ali-Jackson, Esq.Oct 20, 2026Departed
Class A directorDeborah A. RamsdellOct 20, 2026Appointed
Class B directorJohn A. Dawson CBEOct 20, 2026Appointed
Class C directorBruce WendelOct 20, 2026Appointed
COOStephan ToutainAug 25, 2026Departed
CFOLars BoesgaardAug 19, 2026Departed
interim Principal Accounting OfficerJanetta TrochimiukAug 19, 2026Appointed
interim Principal Financial OfficerFrank Bedu-Addo, Ph.D.Aug 19, 2026Appointed

Related companies

Same industry and state, with recent events.

  1. Executive departure

    member of the Board departs: Kamil Ali-Jackson, Esq.

    Kamil Ali-Jackson, Esq., member of the Board of PDS Biotechnology Corp, resigns the role, effective October 18, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: member of the Board

    Source: SEC 8-K, filed Oct 20, 2026

  2. Executive departure

    member of the Board departs: Stephen Glover

    Stephen Glover, member of the Board of PDS Biotechnology Corp, resigns the role, effective October 18, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: member of the Board

    Source: SEC 8-K, filed Oct 20, 2026

  3. Executive departure

    member of the Board departs: Gregory Freitag, J.D., CPA

    Gregory Freitag, J.D., CPA, member of the Board of PDS Biotechnology Corp, resigns the role, effective October 18, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: member of the Board

    Source: SEC 8-K, filed Oct 20, 2026

  4. Executive departure

    member of the Board departs: Otis Brawley, M.D.

    Otis Brawley, M.D., member of the Board of PDS Biotechnology Corp, resigns the role, effective October 18, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: member of the Board

    Source: SEC 8-K, filed Oct 20, 2026

  5. Executive appointment

    Class A director appointed: Deborah A. Ramsdell

    Deborah A. Ramsdell was named Class A director of PDS Biotechnology Corp, effective October 18, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Class A director

    Source: SEC 8-K, filed Oct 20, 2026

  6. Executive appointment

    Class B director appointed: John A. Dawson CBE

    John A. Dawson CBE was named Class B director of PDS Biotechnology Corp, effective October 18, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Class B director

    Source: SEC 8-K, filed Oct 20, 2026

  7. Executive appointment

    Class C director appointed: Bruce Wendel

    Bruce Wendel was named Class C director of PDS Biotechnology Corp, effective October 18, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Class C director

    Source: SEC 8-K, filed Oct 20, 2026

  8. Executive appointment

    Class C director appointed: Patrick Soon-Shiong

    Patrick Soon-Shiong was named Class C director of PDS Biotechnology Corp, effective September 14, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Class C director

    Source: SEC 8-K, filed Sep 14, 2026

Last verified Nov 8, 2026